Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin 5-hydroxytryptamine 2A receptor and 5-hydroxytryptamine 2C receptor are closely related members of the class A G protein-coupled receptor family. They mediate the effects of serotonin in the central nervous system, especially in regions governing cognition, mood, and perception. 5-HT2A and 5-HT2C receptors share primary sequence similarities and activate intracellular signaling mostly via Gq proteins, which, in turn, trigger phospholipase C pathways and result in downstream neurotransmission, gene expression changes, and cellular adaptation. The 5-HT2A receptor is heavily implicated in the pharmacology of hallucinogens and antipsychotics, while 5-HT2C is targeted for obesity and addiction therapies. Both receptors are significant in disorders of mood, cognition, and neuropsychiatric disease, and are frequent molecules of interest in drug discovery
Agonism (activation): induces receptor coupling to Gq protein, triggering intracellular signaling (mainly PLC pathway) Antagonism: blocks receptor activity, prevents serotonin-mediated signaling Inverse agonism: stabilizes the inactive receptor state, reduces baseline activity
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine 2A receptor and Serotonin 5-hydroxytryptamine 2C receptor (5-HT2A receptor and 5-HT2C receptor).